Wire Stories
456Statement by Oasis on the “Opinion on Hokuetsu’s Corporate Governance†by Daio Kaiun (Securities Code: 3865 JT)
* Oasis issues statement on Daio Kaiun Opinion * Daio Kaiun Opinion notes Hokuetsu’s corporate governance issues * Oasis calls on shareholders...
- 428
Elliptic Labs Signs New Contract with a New Leading PC/Laptop Customer
OSLO, Norway–(BUSINESS WIRE)–#AIVirtualPresenceSensor—Elliptic Labs (OSE: ELABS), a global AI software company and the world leader in AI Virtual Smart Sensorsâ„¢ currently deployed...
- 488
UNIDO Announces AI Alliance with Huawei and Global Partners to Help Industries Go Digital
FÉNYESLITKE, Hungary–(BUSINESS WIRE)–Today, the Intelligent Rail & Logistics Forum 2023 was held in Fényeslitke, Hungary. During the forum, the United Nations Industrial...
- 506
Macnica provides motor-specific predictive maintenance services in Asian countries : Mpression Smart Motor Sensor in ASEAN
– Reducing downtime and optimizing maintenance costs for customers in the manufacturing industry – YOKOHAMA, Japan–(BUSINESS WIRE)–Macnica, Inc. (Headquarters: Yokohama City, Kanagawa...
- 495
CSG Earns Top 100 Position Among India’s Best Companies to Work for
BANGALORE, India–(BUSINESS WIRE)–Delivering extraordinary experiences for our customers and our employees is what drives CSG® (NASDAQ: CSGS). Today, CSG was recognized as...
- 508
Latest Data of InnoCare’s Orelabrutinib Presented at the 17th International Conference on Malignant Lymphoma (ICML)
BEIJING–(BUSINESS WIRE)–InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company, today announced the latest clinical data of its Bruton Tyrosine Kinase...
- 522
Takeda and HUTCHMED Announce Publication of Phase 3 FRESCO-2 Results in The Lancet
− Publication shows FRESCO-2 demonstrated treatment with fruquintinib reduced the risk of death by 34% in previously treated metastatic colorectal cancer (0.66...
- 555
SEE Upcoming Event with the Asia Pacific Financial Community
Tokyo, Japan CHARLOTTE, N.C.–(BUSINESS WIRE)–SEE (NYSE: SEE) will participate in the following event. Ted Doheny, President and CEO, and members of his...
- 496
Takeda and HUTCHMED Announce Marketing Authorization Application of Fruquintinib for Previously Treated Metastatic Colorectal Cancer Validated by the European Medicines Agency
— Application Includes Data from Phase 3 FRESCO-2 and FRESCO Clinical Trials, which Demonstrated Superiority of Fruquintinib Plus Best Supportive Care (BSC)...
- 584
CSC Acquires Eddystone Financial Services, Expanding Loan Agency Offering in Australasia
WILMINGTON, Del.–(BUSINESS WIRE)–CSC, a leading provider of business, legal, tax, and digital brand services, announced today the acquisition of Eddystone Financial Services,...
